gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate has been researched along with Benign Neoplasms, Brain in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (12.90) | 18.7374 |
1990's | 5 (16.13) | 18.2507 |
2000's | 5 (16.13) | 29.6817 |
2010's | 15 (48.39) | 24.3611 |
2020's | 2 (6.45) | 2.80 |
Authors | Studies |
---|---|
Tweedle, MF | 1 |
Black, KL; Ding, H; Galstyan, A; Grodzinski, ZB; Holler, E; Israel, LL; Ljubimova, JY; Patil, R; Shatalova, ES; Wagner, S | 1 |
Miller, JH; Pokorney, A; Robison, RK | 1 |
Gu, YJ; Jin, J; Lam, MH; Wong, WT; Xu, Z; Zhang, Y | 1 |
Berger, F; Lahrech, H; Nissou, MF; Perles-Barbacaru, AT; Sarraf, M; van der Sanden, B | 1 |
Bianchi, A; Bouchaud, V; Crémillieux, Y; Lux, F; Moncelet, D; Plissonneau, M; Ribot, EJ; Rizzitelli, S; Tassali, N; Tillement, O; Voisin, P | 1 |
Coppenrath, E; Dietrich, O; Kammer, NN; Kooijman, H; Saam, T; Treitl, KM | 1 |
Azzi, J; Chen, JW; Hannah Degeling, M; Kuijten, MM; Nicolay, K; Tannous, BA; Waterman, P; Weissleder, R; Wojtkiewicz, G | 1 |
Kontopodis, E; Marias, K; Sakkalis, V; Spanakis, M; Van Cauter, S | 1 |
Choi, YS; Kim, JH; Kim, JK; Pae, SJ; Son, WC; Suh, JY; Sung, YS; Woo, DC | 1 |
Barbier, EL; Beaumont, M; Farion, R; Lemasson, B; Rémy, C; Segebarth, C | 1 |
Echner, H; Gharabaghi, A; Heckl, S; Kalbacher, H; Klose, U; Sturzu, A | 1 |
Bonneville, F; Chiras, J; Clarençon, F; Cornu, P; Galanaud, D; Kujas, M; Naggara, O; Rousseau, A | 1 |
Gauler, T; Kraff, O; Ladd, ME; Ladd, SC; Maderwald, S; Mönninghoff, C; Schütt, P; Theysohn, JM; Wanke, I | 1 |
Barbier, EL; Bouchet, A; Coquery, N; Le Duc, G; Lemasson, B; Maisin, C; Rémy, C; Robert, P; Serduc, R; Troprès, I | 1 |
Beissner, RS; Morelli, JN; Runge, VM; Tweedle, M; Williams, JM | 1 |
Farion, R; Lahrech, H; Perles-Barbacaru, AT; van der Sanden, BP | 1 |
Hewer, E; Schwartz, KM; Slopis, JM; Stippich, C; Yu, Y; Zipp, L | 1 |
Corot, C; Rémy, C; Robert, P; Santus, R; Violas, X | 1 |
Barreau, X; Colosimo, C; Gérardin, E; Guézénoc, F; Kirchin, MA; Knopp, MV; Lodemann, KP | 1 |
Brugières, P; Combes, C; Gaston, A; Gray, F; Houhou, S; Ricolfi, F; Sadik, JC; Thomas, P | 1 |
Balériaux, D; De Greef, D; Matos, C | 1 |
Aesch, B; Cotty, P; de Toffol, B; Leproux, F | 1 |
Nowak, PJ; Oudkerk, M; Sijens, PE; van den Bent, MJ; van Dijk, P | 1 |
Benderbous, S; Corot, C; Décorps, M; Dupeyre, R; Farion, R; Fonchy, E; François-Joubert, A; Lahrech, H; Rémy, C; Rubin, C | 1 |
Ballesteros, P; Cerdán, S; Coles, JA; Farion, R; García-Martín, ML; Hérigault, G; Rémy, C; Ziegler, A | 1 |
Gelblum, DY; Jacobson, S; Runge, VM | 1 |
Adelman, LS; Jacobson, S; Kaufman, DM; Runge, VM; Wood, ML | 1 |
Baert, AL; Decrop, E; Marchal, G; Plets, C; Wilms, G | 1 |
Baert, AL; Decrop, E; Marchal, G; Van Hecke, P; Wilms, G | 1 |
Adelman, LS; Jacobson, S; Kaufman, D; Runge, VM; Wood, ML | 1 |
2 trial(s) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Benign Neoplasms, Brain
Article | Year |
---|---|
A comparison of Gd-BOPTA and Gd-DOTA for contrast-enhanced MRI of intracranial tumours.
Topics: Aged; Brain Neoplasms; Contrast Media; Cross-Over Studies; Double-Blind Method; Female; Glioma; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds; Sensitivity and Specificity | 2004 |
Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA.
Topics: Brain; Brain Neoplasms; Contrast Media; Double-Blind Method; Female; Gadolinium DTPA; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurologic Examination; Organometallic Compounds; Pentetic Acid; Postoperative Complications; Spinal Cord; Spinal Cord Neoplasms | 1993 |
29 other study(ies) available for gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate and Benign Neoplasms, Brain
Article | Year |
---|---|
Next-Generation MRI Contrast Agents: Still Including Gadolinium.
Topics: Brain Neoplasms; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds | 2020 |
Single- and Multi-Arm Gadolinium MRI Contrast Agents for Targeted Imaging of Glioblastoma.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Disease Models, Animal; Female; Glioblastoma; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Meglumine; Mice, Nude; Nanostructures; Organometallic Compounds; Xenograft Model Antitumor Assays | 2020 |
Evaluation of the effect of switching from a linear to a macrocyclic contrast agent on the T
Topics: Astrocytoma; Brain; Brain Neoplasms; Cerebellar Nuclei; Contrast Media; Follow-Up Studies; Gadolinium DTPA; Globus Pallidus; Heterocyclic Compounds; Humans; Linear Models; Magnetic Resonance Imaging; Male; Organometallic Compounds; Retrospective Studies; Rhabdomyosarcoma; Young Adult | 2019 |
Upconversion nanoparticles conjugated with Gd(3+) -DOTA and RGD for targeted dual-modality imaging of brain tumor xenografts.
Topics: Animals; Brain Neoplasms; Cell Death; Cell Line, Tumor; Endocytosis; Heterocyclic Compounds; Humans; Magnetic Phenomena; Magnetic Resonance Imaging; Mice, Inbred BALB C; Mice, Nude; Multimodal Imaging; Nanoparticles; Oligopeptides; Organometallic Compounds; Spectrophotometry, Atomic; Surface Properties; Xenograft Model Antitumor Assays | 2013 |
Rapid-Steady-State-T1 signal modeling during contrast agent extravasation: toward tumor blood volume quantification without requiring the arterial input function.
Topics: Animals; Blood Volume; Blood Volume Determination; Brain Neoplasms; Cell Line, Tumor; Computer Simulation; Contrast Media; Extravasation of Diagnostic and Therapeutic Materials; Heterocyclic Compounds; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Models, Biological; Neovascularization, Pathologic; Organometallic Compounds; Rats; Rats, Inbred F344 | 2015 |
Orotracheal administration of contrast agents: a new protocol for brain tumor targeting.
Topics: Administration, Oral; Animals; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Female; Glioblastoma; Heterocyclic Compounds; Image Enhancement; Magnetic Resonance Imaging; Metabolic Clearance Rate; Mice; Mice, Nude; Nanoparticles; Organometallic Compounds; Reproducibility of Results; Sensitivity and Specificity; Tissue Distribution | 2015 |
Comparison of contrast-enhanced modified T1-weighted 3D TSE black-blood and 3D MP-RAGE sequences for the detection of cerebral metastases and brain tumours.
Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Contrast Media; Female; Heterocyclic Compounds; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Organometallic Compounds; Retrospective Studies; Young Adult | 2016 |
Multimodal targeted high relaxivity thermosensitive liposome for in vivo imaging.
Topics: Animals; Biotin; Brain Neoplasms; Cell Line, Tumor; Contrast Media; ErbB Receptors; Gadolinium DTPA; Gene Expression; Glioma; Green Fluorescent Proteins; Heterocyclic Compounds; Humans; Injections, Subcutaneous; Lipid Bilayers; Liposomes; Magnetic Resonance Imaging; Mice; Mice, Nude; Neoplasm Transplantation; Optical Imaging; Organometallic Compounds; Protein Binding; Rhodamines; Streptavidin; Temperature | 2015 |
Assessment of DCE-MRI parameters for brain tumors through implementation of physiologically-based pharmacokinetic model approaches for Gd-DOTA.
Topics: Brain; Brain Neoplasms; Cerebrovascular Circulation; Computer Simulation; Contrast Media; Female; Glioblastoma; Glomerular Filtration Rate; Healthy Volunteers; Heterocyclic Compounds; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Models, Biological; Organometallic Compounds; Renal Insufficiency; Tissue Distribution | 2016 |
Difference in the intratumoral distributions of extracellular-fluid and intravascular MR contrast agents in glioblastoma growth.
Topics: Animals; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cerebral Arteries; Contrast Media; Dextrans; Extracellular Fluid; Glioblastoma; Heterocyclic Compounds; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Mice; Mice, Inbred BALB C; Organometallic Compounds; Tissue Distribution | 2016 |
Characterization of tumor angiogenesis in rat brain using iron-based vessel size index MRI in combination with gadolinium-based dynamic contrast-enhanced MRI.
Topics: Animals; Brain Neoplasms; Cell Membrane Permeability; Contrast Media; Dextrans; Ferrosoferric Oxide; Gadolinium; Glioma; Heterocyclic Compounds; Iron; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Microvessels; Neovascularization, Pathologic; Organometallic Compounds; Rats; Rats, Wistar | 2009 |
Imaging of human glioma cells by means of a Syndecan-4 directed DOTA-conjugate.
Topics: Brain Neoplasms; Cell Line, Tumor; Chromatography, High Pressure Liquid; Contrast Media; Flow Cytometry; Glioma; Heterocyclic Compounds; Humans; Microscopy, Confocal; Organometallic Compounds; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Syndecan-4 | 2010 |
Intracranial solitary fibrous tumor: imaging findings.
Topics: Adult; Brain Neoplasms; Choline; Contrast Media; Diffusion Magnetic Resonance Imaging; Female; Heterocyclic Compounds; Humans; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuroimaging; Organometallic Compounds; Retrospective Studies; Solitary Fibrous Tumors; Tomography, X-Ray Computed | 2011 |
Imaging of brain metastases of bronchial carcinomas with 7 T MRI - initial results.
Topics: Adult; Aged; Brain; Brain Neoplasms; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Contrast Media; Dose-Response Relationship, Drug; Female; Heterocyclic Compounds; Humans; Image Enhancement; Image Processing, Computer-Assisted; Infusions, Intravenous; Intracranial Hemorrhages; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Staging; Organometallic Compounds; Prospective Studies; Sensitivity and Specificity | 2010 |
Monitoring blood-brain barrier status in a rat model of glioma receiving therapy: dual injection of low-molecular-weight and macromolecular MR contrast media.
Topics: Analysis of Variance; Animals; Area Under Curve; Benzenesulfonates; Blood-Brain Barrier; Brain Neoplasms; Contrast Media; Disease Models, Animal; Glioma; Heterocyclic Compounds; Macromolecular Substances; Magnetic Resonance Imaging; Male; Neovascularization, Pathologic; Niacinamide; Organometallic Compounds; Phenylurea Compounds; Pyridines; Random Allocation; Rats; Sorafenib | 2010 |
Evaluation of a fibrin-binding gadolinium chelate peptide tetramer in a brain glioma model.
Topics: Animals; Area Under Curve; Brain Neoplasms; Contrast Media; Disease Models, Animal; Fibrin; Fluorescent Antibody Technique, Direct; Gadolinium DTPA; Glioma; Heterocyclic Compounds; Organometallic Compounds; Rats; Rats, Inbred F344 | 2011 |
How stereological analysis of vascular morphology can quantify the blood volume fraction as a marker for tumor vasculature: comparison with magnetic resonance imaging.
Topics: Animals; Blood Volume; Blood Volume Determination; Brain Mapping; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Glioma; Heterocyclic Compounds; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Microscopy, Fluorescence; Microvessels; Models, Anatomic; Neoplasm Transplantation; Neovascularization, Pathologic; Organometallic Compounds; Rats; Rats, Wistar | 2012 |
Magnetic resonance imaging and computed tomography findings in pediatric giant cell glioblastoma.
Topics: Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cerebral Ventricles; Child; Contrast Media; Diffusion Magnetic Resonance Imaging; Epilepsy, Generalized; Glioblastoma; Heterocyclic Compounds; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Internal Capsule; Iohexol; Magnetic Resonance Imaging; Male; Multidetector Computed Tomography; Organometallic Compounds; Stereotaxic Techniques | 2012 |
Comparison of the tumoral biodistribution of P792, a rapid clearance blood pool agent and Gd-DOTA in a C6 glioma cerebral tumor model in rats.
Topics: Animals; Brain Neoplasms; Contrast Media; Diffusion; Female; Glioma; Heterocyclic Compounds; Magnetic Resonance Imaging; Organometallic Compounds; Rats; Rats, Wistar; Tissue Distribution | 2002 |
[Imagery of human immunodeficiency virus (HIV) encephalitis].
Topics: Adult; AIDS Dementia Complex; AIDS-Related Opportunistic Infections; Atrophy; Brain Neoplasms; Contrast Media; Cytomegalovirus Infections; Encephalitis, Viral; Female; Gadolinium; Heterocyclic Compounds; Humans; Leukoencephalopathy, Progressive Multifocal; Lymphoma, AIDS-Related; Magnetic Resonance Imaging; Male; Organometallic Compounds; Tomography, X-Ray Computed; Toxoplasmosis, Cerebral | 1995 |
MRI of cranial chordomas: the value of gadolinium.
Topics: Adult; Aged; Brain Neoplasms; Brain Stem; Chordoma; Cranial Fossa, Posterior; Diagnosis, Differential; Epidural Neoplasms; Female; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Male; Occipital Bone; Organometallic Compounds; Skull Neoplasms | 1993 |
1H chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast.
Topics: Aspartic Acid; Brain; Brain Neoplasms; Choline; Contrast Media; Creatine; Fourier Analysis; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Hydrogen; Image Enhancement; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Organometallic Compounds; Pentetic Acid; Regression Analysis | 1997 |
A new gadolinium-based contrast agent for magnetic resonance imaging of brain tumors: kinetic study on a C6 rat glioma model.
Topics: Animals; Brain Neoplasms; Contrast Media; Female; Gadolinium; Glioblastoma; Heterocyclic Compounds; Magnetic Resonance Imaging; Organometallic Compounds; Rats; Rats, Sprague-Dawley | 2001 |
Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites.
Topics: Animals; Aspartic Acid; Brain Neoplasms; Buffers; Choline; Contrast Media; Creatine; Extracellular Space; Female; Glioma; Heterocyclic Compounds; Hydrogen-Ion Concentration; Imidazoles; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Organometallic Compounds; Phosphocreatine; Propionates; Protons; Rats; Rats, Wistar | 2001 |
Gd HP-DO3A--experimental evaluation in brain and renal MR.
Topics: Animals; Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Glioma; Heterocyclic Compounds; Image Enhancement; Kidney; Kidney Cortex; Kidney Medulla; Magnetic Resonance Imaging; Male; Meningeal Neoplasms; Models, Structural; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred F344; Time Factors | 1991 |
Experimental trials with Gd(DO3A)--a nonionic magnetic resonance contrast agent.
Topics: Animals; Brain Neoplasms; Contrast Media; Gadolinium; Gadolinium DTPA; Glioma; Heterocyclic Compounds; Kidney Medulla; Magnetic Resonance Imaging; Male; Neoplasm Transplantation; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred F344 | 1989 |
A case of intracranial chordoma investigated by MRI and CT studies.
Topics: Aged; Brain Neoplasms; Chordoma; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Humans; Magnetic Resonance Imaging; Organometallic Compounds; Tomography, X-Ray Computed | 1989 |
MR imaging of the brain: preliminary results with a gradient echo sequence after paramagnetic contrast enhancement.
Topics: Brain Diseases; Brain Neoplasms; Contrast Media; Gadolinium; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Imaging; Organometallic Compounds; Time Factors | 1989 |
MR imaging of rat brain glioma: Gd-DTPA versus Gd-DOTA.
Topics: Animals; Brain Neoplasms; Gadolinium; Gadolinium DTPA; Glioma; Heterocyclic Compounds; Magnetic Resonance Imaging; Male; Organometallic Compounds; Pentetic Acid; Rats; Rats, Inbred Strains | 1988 |